There was a numerical reduction in the percentage of haptoglobin+ sputum macrophages in COPD patients (57%) and HS (51%) compared to HNS (75%), but this was not significant (ANOVA, p = 0.25; Figure 3). The gene discussed is HP; the disease is chronic obstructive pulmonary disease.